SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-017889
Filing Date
2018-07-30
Accepted
2018-07-30 16:06:24
Documents
46
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q odt-10q_20180630.htm 10-Q 667927
2 EX-31.1 odt-ex311_6.htm EX-31.1 17010
3 EX-31.2 odt-ex312_8.htm EX-31.2 17015
4 EX-32.1 odt-ex321_7.htm EX-32.1 15200
  Complete submission text file 0001564590-18-017889.txt   2316303

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT odt-20180630.xml EX-101.INS 327715
6 XBRL TAXONOMY EXTENSION SCHEMA odt-20180630.xsd EX-101.SCH 27568
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE odt-20180630_cal.xml EX-101.CAL 21506
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE odt-20180630_def.xml EX-101.DEF 60610
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20180630_lab.xml EX-101.LAB 193473
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20180630_pre.xml EX-101.PRE 142837
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38318 | Film No.: 18977682
SIC: 2834 Pharmaceutical Preparations